Levels of residues from veterinary drugs found in animals and animal-derived food remain low in the European Union

Levels of residues from veterinary drugs and other substances found in animals and animal-derived food remain low in the European Union, according to the latest report from EFSA.

The report looks at variety of substance groups, including hormones, antibacterials, environmental contaminants, prohibited substances, and other veterinary drugs. EFSA’s annual report for 2022 includes data reported by Member States[1], Iceland and Norway.

In 2022, the percentage of non-compliant samples was 0.18%, which is comparable to the previous 13 years when non-compliance ranged from 0.17% to 0.37%. The figure for 2021 was 0.17%.

The overall level of non-compliance in targeted samples (i.e., those taken to detect illegal use or check non-compliance with the maximum permitted levels) was 0.27% which is comparable to the previous four years (0.24%-0.35%) and slightly higher than in 2021 (0.24%).

The comprehensive dataset for the report, totalling approximately 13 million analytical results, will soon be made available through the EFSA Knowledge Junction. This open repository is designed to enhance transparency, reproducibility, and the usability of evidence in food and feed safety risk assessments.

Report for 2022 on the results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products. 


  • Please enter a comment

Name *
Email address *
Comment *

* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.

I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies

More news

Zoetis is Redefining the Feline Veterinary Experience with the Commercial Launch of Bonqat® (pregabalin oral solution) in the U.S.


Spatio-temporal patterns of tick-borne disease diagnoses in Indiana, USA (2009–2018)


Abdominal ultrasonographic findings of cats with feline infectious peritonitis: an update


Pseudohyperkalemia in horses with rhabdomyolysis reported by an enzymatic chemistry analyzer


Retrospective evaluation of prognosis and survival with various immunosuppressants in 82 dogs diagnosed with meningoencephalitis of unknown etiology (2010-2021).




News of interest


Copyright © 2024 - All Rights Reserved
ISSN 2768-198X